{"id":"NCT00911144","sponsor":"GlaxoSmithKline","briefTitle":"Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine","officialTitle":"Booster Vaccination With Pneumococcal Vaccine GSK1024850A or Prevenar™ Co-administered With Hiberix™ in Children Primed With the Same Vaccines","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-06-11","primaryCompletion":"2010-01-11","completion":"2010-01-11","firstPosted":"2009-06-01","resultsPosted":"2011-01-19","lastUpdate":"2018-09-20"},"enrollment":450,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Streptococcal"],"interventions":[{"type":"BIOLOGICAL","name":"GSK Biologicals' Synflorix™ (Pneumococcal vaccine GSK1024850A)","otherNames":["Pneumococcal vaccine GSK1024850A"]},{"type":"BIOLOGICAL","name":"Wyeth-Lederle's Prevenar™","otherNames":[]},{"type":"BIOLOGICAL","name":"GSK Biologicals' Hiberix™","otherNames":["Hib"]}],"arms":[{"label":"Synflorix Group","type":"EXPERIMENTAL"},{"label":"Prevenar Group","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the reactogenicity, safety and immunogenicity of a booster (fourth) dose of pneumococcal vaccine GSK1024850A when co-administered with Hiberix at 12-18 months of age, in children primed with the same vaccines in primary study NCT00680914.","primaryOutcome":{"measure":"Number of Subjects Reporting Grade 3 Adverse Events","timeFrame":"Within 31 days (Day 0 - Day 30) after booster vaccination.","effectByArm":[{"arm":"Synflorix Group","deltaMin":42,"sd":null},{"arm":"Prevenar Group","deltaMin":13,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":13},"locations":{"siteCount":14,"countries":["South Korea"]},"refs":{"pmids":["21817957"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":335},"commonTop":["Redness at the injection site","Irritability","Pain at the injection site","Swelling at the injection site","Loss of appetite"]}}